Back to Search Start Over

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration.

Authors :
Husereau D
Drummond M
Petrou S
Greenberg D
Mauskopf J
Augustovski F
Briggs AH
Moher D
Loder E
Carswell C
Source :
PharmacoEconomics [Pharmacoeconomics] 2015 May; Vol. 33 (5), pp. 535-6.
Publication Year :
2015

Details

Language :
English
ISSN :
1179-2027
Volume :
33
Issue :
5
Database :
MEDLINE
Journal :
PharmacoEconomics
Publication Type :
Editorial & Opinion
Accession number :
25893576
Full Text :
https://doi.org/10.1007/s40273-015-0277-8